You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR METHAZOLAMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for METHAZOLAMIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00257829 ↗ Improving Tumor Oxygenation in Cervical Cancer Withdrawn University of California, Irvine Phase 2 2004-07-01 The Phenomenon of Tumor Hypoxia Many solid tumors are relatively resistant to treatment with ionizing radiation and certain chemotherapeutic agents such as anthracyclines that are affected adversely by acidic pH. These effects have primarily been attributed to the presence of hypoxic cells within the tumor. The relevance of hypoxia with respect to failure of radiotherapy to cure certain malignancies has had a chequered history. However, in recent years the evidence that hypoxia plays a central role in relative radioresistance has become more compelling. Since approximately two-thirds of all women suffering from cervical carcinoma receive radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation as a component of their therapy, an enhanced understanding of the interactions between hypoxia and radiation resistance is critical to improving outcome among those with cervical cancer.
NCT01587027 ↗ Safety Evaluation of Aminophylline and Methazolamide Completed Defense Advanced Research Projects Agency Phase 1 2011-12-01 This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
NCT01587027 ↗ Safety Evaluation of Aminophylline and Methazolamide Completed University of Colorado, Denver Phase 1 2011-12-01 This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
NCT01587027 ↗ Safety Evaluation of Aminophylline and Methazolamide Completed Poudre Valley Health System Phase 1 2011-12-01 This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
NCT01702025 ↗ Rapid Acclimatization to Hypoxia at Altitude Completed Defense Advanced Research Projects Agency Phase 1/Phase 2 2012-06-01 In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.
NCT01702025 ↗ Rapid Acclimatization to Hypoxia at Altitude Completed University of Colorado, Denver Phase 1/Phase 2 2012-06-01 In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for METHAZOLAMIDE

Condition Name

Condition Name for METHAZOLAMIDE
Intervention Trials
Mountain Sickness 2
Hypoxia 1
Physiological Function in Low Oxygen Environment 1
Altitude Sickness 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for METHAZOLAMIDE
Intervention Trials
Altitude Sickness 4
Hypoxia 3
Glaucoma 2
Glaucoma, Open-Angle 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for METHAZOLAMIDE

Trials by Country

Trials by Country for METHAZOLAMIDE
Location Trials
United States 5
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for METHAZOLAMIDE
Location Trials
Colorado 3
Michigan 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for METHAZOLAMIDE

Clinical Trial Phase

Clinical Trial Phase for METHAZOLAMIDE
Clinical Trial Phase Trials
Phase 4 5
Phase 3 1
Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for METHAZOLAMIDE
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 2
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METHAZOLAMIDE

Sponsor Name

Sponsor Name for METHAZOLAMIDE
Sponsor Trials
University of Colorado, Denver 4
Defense Advanced Research Projects Agency 2
University of British Columbia 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for METHAZOLAMIDE
Sponsor Trials
Other 13
U.S. Fed 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.